β –Blockers in reactive airway disease 414-417
Bharti Chogtu, MBBS, MD Pharmacology
Associate Professor, Pharmacology, Kasturba Medical College,
Manipal University, Manipal, Karnataka- 576104
Phone No. 9901728668
Beta-2- adrenergic agonists agonists are used in the treatment of reversible airway disease. β- blockers, due to their bronchoconstrictor effects, are supposed to be deleterious in such patients. In this review, we are putting forth some recent studies and meta analysis, which indicate that the chronic use of β- blockers in patients with reversible airway disease does not produce pulmonary impairment. Also, these drugs need not be withheld from patients with other diseases like hypertension, after weighing the risk: benefit ratio.